Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Frequent and Chronic Tension-type Headache
NCT04857671Phase 3Completed
- Sponsor
- Helse Nord-Trøndelag
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in tension-type headache (TTH), sponsored by Helse Nord-Trøndelag. Started Oct 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
tension-type headache (TTH)
Beyond the preview
Go deeper on NCT04857671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04857671.